ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 201 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,667,200 | -79.2% | 80,000 | -51.5% | 0.55% | -74.0% |
Q2 2020 | $7,998,000 | -60.1% | 165,000 | -78.0% | 2.11% | -49.3% |
Q2 2019 | $20,048,000 | -17.0% | 750,000 | -16.7% | 4.16% | -34.1% |
Q1 2019 | $24,165,000 | +1095.7% | 900,000 | +620.0% | 6.31% | +761.3% |
Q4 2018 | $2,021,000 | -90.3% | 125,000 | -87.5% | 0.73% | -83.4% |
Q3 2018 | $20,760,000 | +154.1% | 1,000,000 | +86.9% | 4.41% | +83.5% |
Q2 2018 | $8,169,000 | -9.1% | 535,000 | +33.8% | 2.40% | +32.2% |
Q1 2018 | $8,988,000 | +118.9% | 400,000 | +267.0% | 1.82% | +108.5% |
Q3 2017 | $4,106,000 | -46.5% | 109,000 | -60.4% | 0.87% | -45.3% |
Q2 2017 | $7,670,000 | -60.0% | 275,000 | -50.6% | 1.59% | -55.4% |
Q1 2017 | $19,157,000 | +47.6% | 557,200 | +23.8% | 3.57% | +14.3% |
Q4 2016 | $12,978,000 | +104.0% | 450,000 | +125.0% | 3.12% | +202.6% |
Q3 2016 | $6,362,000 | -46.5% | 200,000 | -52.9% | 1.03% | -84.7% |
Q1 2016 | $11,883,000 | +33.3% | 425,000 | +70.0% | 6.72% | +84.3% |
Q4 2015 | $8,913,000 | +127.9% | 250,000 | +108.3% | 3.65% | +419.1% |
Q1 2015 | $3,911,000 | – | 120,000 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |